Most weight change is gradual and explained by the usual mix of biology, behaviour and environment. It becomes a red flag when it is rapid, unexplained, or paired with other symptoms — new headaches or vision changes, purple stretch marks and easy bruising, a recently started medication, or significant unintentional weight loss. Those patterns warrant investigation.
Most weight change is not a red flag — but some is
The everyday reasons weight drifts upward — appetite biology defending a higher set point, a food environment built for overconsumption, aging, poor sleep, stress and reduced activity — are common, real, and not the subject here. → Why Is Weight So Hard to Lose?
This page covers the minority of cases in which weight change signals something specific: a medication, a hormonal disease, a problem in the brain's weight-control centres, or, rarely, a tumour. The aim is to investigate when the pattern warrants it and to avoid over-testing when it does not. A number moving is not itself an emergency; the pattern — the speed, the direction, the accompanying symptoms — is what indicates whether to look deeper. → How Obesity Should Be Evaluated
The red-flag patterns
Weight change warrants investigation when one or more of these is present:
- Rapid change — significant gain or loss over weeks to a few months, out of proportion to any change in eating or activity.
- Truly unexplained change — no plausible dietary, activity, medication or life-context reason.
- Significant unintentional weight loss — a red flag in its own right, since it can point to cancer, thyroid overactivity, diabetes, malabsorption, depression or other illness, and it generally warrants prompt evaluation. This page concerns gain, but unintended loss should not be set aside.
- Accompanying symptoms — headaches or vision changes; purple striae, easy bruising, thin skin or proximal muscle weakness; extreme, relentless hunger; menstrual disturbance or milk discharge; a newly started medication that lines up in time.
- Early-onset severe obesity — beginning in early childhood with extreme hyperphagia, which suggests a possible genetic or syndromic cause. → Genetics of Obesity
Where none of these is present and the change is gradual, a full secondary hunt is usually unnecessary, and screening for obesity's harms is the more useful step. → How Obesity Should Be Evaluated
Drug-induced weight gain, the first thing to check
Medication is the most common and most fixable secondary cause. It is high-yield, cheap to assess and frequently missed, and a weight trend that lines up in time with a medication start is a strong clue.
| Class | Note |
|---|---|
| Antipsychotics | Several cause gain, some markedly. |
| Antidepressants | Certain agents; effects vary by drug. |
| Mood stabilizers / antiseizure drugs | Some cause gain; others are weight-neutral or cause loss. |
| Corticosteroids | Systemic use can drive rapid central gain and mimic features of cortisol excess. |
| Some diabetes medications | Insulin and sulfonylureas in particular. GLP-1 agonists and SGLT2 inhibitors tend toward weight loss. |
| Certain hormonal agents | Some contraceptives and progestins, some hormone therapies, and a few others. |
None of this is a reason to stop a needed medication. It is a reason to review it, since a weight-neutral or weight-favourable alternative sometimes exists, and the decision is always weighed against why the drug was prescribed in the first place. Grade A 🟢 → How Obesity Should Be Evaluated
Hypothyroidism: common, with a modest effect
An underactive thyroid is the endocrine cause patients ask about most, and a one-time check is reasonable because the condition is common and treatable. The effect size is modest: hypothyroidism causes modest weight gain, much of it fluid, a normal TSH effectively rules it out as a major driver, and treating it produces modest rather than dramatic loss. Overt hypothyroidism usually brings other clues — fatigue, cold intolerance, constipation, dry skin. Grade A 🟢 (real but modest; a normal TSH largely excludes it) → Obesity & Hormones · Thyroid & weight (Hashiexperts)
Cushing's syndrome: rare, specific, important
Cushing's syndrome — pathological cortisol excess — is uncommon, but it is the secondary cause not to miss, because it is treatable and has a recognizable picture: rapid central weight gain with relatively thin limbs; a rounded ("moon") face and a fatty upper-back pad; purple or violaceous striae, easy bruising and thin skin; proximal muscle weakness; and often hard-to-control hypertension and high glucose.
Testing is directed by that constellation, not by central fat alone, which is far more often ordinary obesity. Cortisol excess can arise from steroid medication, which is the common route, or less often from a pituitary or adrenal tumour or an ectopic source. "Adrenal fatigue" is a separate claim and is not a recognized diagnosis. Grade A 🟢 → Obesity & Hormones
Hypothalamic, pituitary and rare causes
The hypothalamus is the brain's weight-and-appetite control centre, so disease or damage there can drive genuine and sometimes severe secondary weight gain. The remaining causes are uncommon, and each is opened by specific clues rather than applied to everyone.
| Cause | What points to it | Grade |
|---|---|---|
| Hypothalamic obesity | Tumours in the region (for example craniopharyngioma) and their treatment by surgery or radiation, traumatic brain injury, and certain infiltrative or developmental conditions. Suspect it when gain is rapid or severe and paired with new or persistent headaches or visual changes, a history of brain injury, cranial surgery or radiation, or other pituitary hormone abnormalities. | Grade B 🟡 |
| Pituitary disease | Includes prolactinoma and, less commonly, growth-hormone or other axis problems. Menstrual disturbance, low libido or milk discharge suggests a prolactin-secreting tumour. Investigated when specific features point there, not routinely. | Grade B 🟡 |
| Insulinoma | A rare insulin-secreting tumour causing recurrent hypoglycaemia; because people eat to relieve the symptoms, it can produce weight gain. The hallmark is documented low blood sugar with symptoms that resolve on eating (Whipple's triad), not weight gain alone, so it is pursued when hypoglycaemia is the story. | Grade C 🟠 |
| Genetic and syndromic obesity | Monogenic forms (MC4R, leptin/LEPR, POMC) and syndromic forms (Prader-Willi, Bardet-Biedl) present with early-onset severe obesity and extreme hyperphagia; some have targeted treatment with setmelanotide. → Genetics of Obesity | Grade B 🟡 |
| Fluid retention | Heart, kidney or liver disease, or certain medications, can cause rapid weight gain that is water rather than fat — usually with swelling, and calling for a different evaluation. | Grade B 🟡 |
When to investigate and when to reassure
| Situation | Reasonable step |
|---|---|
| Gradual gain, no other symptoms, plausible life or behaviour context | Screen for obesity's harms; a one-time thyroid check; medication review. No broad secondary hunt. → How Obesity Should Be Evaluated |
| New medication that lines up in time | Review the medication; consider alternatives with the prescriber. |
| Rapid central gain + striae/bruising/weakness | Evaluate for Cushing's. |
| Rapid/severe gain + headaches/visual or menstrual changes | Evaluate for hypothalamic/pituitary cause. |
| Early-onset severe obesity + extreme hyperphagia | Consider genetic/syndromic evaluation. |
| Recurrent hypoglycaemia driving eating | Evaluate for insulinoma (document hypoglycaemia first). |
| Significant unintentional weight loss | Prompt evaluation — this is its own red flag. |
The depth of investigation is matched to the pattern presented, which is neither a rare-tumour differential for every patient nor a dismissal of a genuine signal as lifestyle. Deciding which column a particular weight history falls into is what an individual endocrinology assessment is for. → The WeightExperts Clinical Approach
Questions patients ask
When is weight gain actually a red flag?
When it is rapid, unexplained, or paired with other symptoms — new headaches or vision changes, purple striae with easy bruising, a newly started medication that lines up in time, or severe early-onset obesity. Gradual gain without other features usually is not. Grade A 🟢 → How Obesity Should Be Evaluated
Which medications cause weight gain?
Several classes: some antipsychotics and antidepressants, some antiseizure and mood-stabilizer drugs, corticosteroids, and certain diabetes medications including insulin and sulfonylureas, among others. A review is worthwhile, since a weight-neutral alternative sometimes exists, but a prescribed drug is not stopped without the prescriber. Grade A 🟢
Could weight gain be a thyroid problem?
Possibly, though the effect is modest and a normal TSH largely rules it out as a major driver. Hypothyroidism usually brings other clues such as fatigue, cold intolerance and constipation, and treating it produces modest rather than dramatic loss. A one-time check is reasonable. Grade A 🟢 → Thyroid & weight (Hashiexperts)
How is Cushing's syndrome recognized?
By a specific picture: rapid central weight gain, a rounded face, purple stretch marks, easy bruising, thin skin, muscle weakness, and hard-to-control blood pressure and glucose. Central fat alone is far more often ordinary obesity, so testing follows the constellation. Grade A 🟢 → Obesity & Hormones
What is hypothalamic obesity?
Weight gain caused by damage or disease in the hypothalamus, the brain's appetite-and-weight control centre — from tumours in that region such as craniopharyngioma, from their treatment, or from brain injury. It is uncommon and usually accompanied by other neurological or hormonal clues. Grade B 🟡
Can a tumour cause weight gain?
Rarely. A pituitary or hypothalamic-region tumour can, and an insulinoma causes hypoglycaemia that leads to eating and gain. Both are uncommon and come with specific clues — neurological features, or documented low blood sugar — rather than weight change alone. Grade C 🟠
Written by Darius A. Schneider, MD, PhD · Board-Certified Endocrinologist (ECNU) · Last updated: Oct 2026 · References: Endocrine Society guidance on Cushing's syndrome and secondary obesity; AACE/OMA obesity evaluation guidance; reviews of drug-induced weight gain; hypothalamic obesity and pituitary-disease literature; diagnostic criteria for insulinoma (Whipple's triad). Cross-references: Hashiexperts (thyroid), MenoExperts (menopause), TestoExperts (men's hormones — forthcoming). Educational; not individualized medical advice.
